版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、急性腎衰竭,Acute Renal Failure (ARF),DEFINITIONS AND INCIDENCE,Acute renal failure (ARF) is a syndrome characterized by rapid decline in glomerular filtration rate(GFR) and retention of nitrogenous wa
2、ste products such as blood urea nitrogen (BUN) and creatinine. ARF complicates approximately 5% of hospital admissions and up to 30% of admissions to intensive care units.,,CLASSIFICATION,Prerenal azot
3、emia Intrinsic renal azotemia Postrenal azotemia,,ETIOLOGY OF ARF,Prerenal Azotemia,Intravascular Volume Depletion Decreased Cardiac Output Systemic Vasodilatation Renal Vasoconstriction Pharmacologic Agent
4、s (ACEI or NSAIDs),ETIOLOGY OF ARF,Postrenal Azotemia Ureteric Obstruction Bladder Neck Obstruction Urethral Obstruction,ETIOLOGY OF ARF,Intrinsic Renal Azotemia Diseases Involving Large Renal Vessels Dise
5、ases of Glomeruli And Microvasculature Acute Tubule Necrosis Diseases of the Tubulointerstitium,急性腎小管壞死,Acute Tubule Necrosis (ATN),ETIOLOGY OF ATN,Renal Ischemia(50%) Nrphrotoxins (35%)
6、 Exogenous Endogenous,PATHOPHYSIOLOGY OF ATN,Intrarenal Vasoconstriction Tubular Dysfunction,Role of Hemodynamic alterations in ATN,Reduction in Total Renal Blood Flow Regional Disturbance in
7、 Renal Blood Flow and Oxygen Supply Edothelin (ET) / NO (EDNO) Other Endothelial Vasoconstrctors The Tubulo-glomerular Feed Back,,Role of Tubule Dysfunction in ATN,Two Major TubularAbnormalities:
8、 Obstrction Backleak,Metabolic Responses of Tubule cells to Injury,ATP Depletion Cell Swelling Intyacellular Free Calcium↑ Intyacellular Acidosis Phospholipase Activation
9、 Protease Activation Oxidant Injury Inflammatory Respose,Pathology,,Clinical Presentation of ATN,The Clinical Course of ATN: The Initiation Phase The Maintenance Phase
10、 The Recovery Phase,The Initiation Phase,GFR↓Lasting Hours or DaysEvidence of true Volume DepletionDecreeced Effective Circulatory VolumeTreatment with NSAIDs or ACEI,The Maintenance Phase,GRR 5 ~ 10 ml/minLast
11、ing 1 ~ 2 WeeksOliguric ARF high catabolismNonoliguric ARFUremic Syndrome,High Catabolic State,Daily Increase in BUN >10.1~17.9 mmol/LDaily Increase in Serum Creatinine >176.8μmol/LDaily Increase in Serum Pot
12、assium >1~2 mmol/LDaily Decrease in Serum HCO 3 ->2 mmol/L,The Uremic Syndrome,General Complications of ARF: Gastrointestinal Cardiovascular Respiratory
13、 Neurologic Hematologic Infectious,The Uremic Syndrome,Homeostatic Disorder of water,Electrolyte and Acid-alkali Balance: Volume Overload Metaboli
14、c Acidosis Hyperkalemia Hyponatremia Hypocalcemia Hyperphosphatemia,The Recovery Phase,The Period of Repair and Regeneration of Renal Tissue: Gradual In
15、crease in Urine Output “Post-ATN” Diuresis Fall in BUN and Scr Recovery of GFR/ Tubule function,Lab Examination,Blood Routine Test and Chemistry Assays: Animia, RBC ↓, Hb ↓
16、 BUN and Scr↑ Na + ↓ ,K+↑,Ca2+↓,P3+ ↑ pH ↓,AG ↑,HCO3- ↓,Lab Examination,Diagnostic Index Prerenal Renal Specific Gravity > 1.020 ~ 1.010 Osm
17、olality(mOsm/Kg H2O) > 500 ~ 300 Urinary Na+ (mmol/L) 20 Ucr/Scr > 40 8 20 1 Fraction
18、al Excretion of Na+ 1 Urine Sediment Hyaline Brown ranular,,,,Lab Examination,Radiologic Evaluation: Plain Abdominal film Renal Ultrasonography
19、 IVP Renal angiography Renal Biopsy,Diagnosis Differentiation:,prerenal azotemia postrenal azotemia Glomerulonephritis/Vasculitis HUS/T
20、TP Interstitial Nephritis Renal Artery Thrombosis Renal vein thrombosis,Management of ARF (一),Correction of Reversible causes Prevention of additional
21、 Injury Maintaining Fluid balance,Management of ARF (二),Maintaining Fluid balance Fluid Intake : 500ml + The Amount of Urine in The Preceding 24 Hours,Management of ARF (三),Nutrition E
22、negy Intake:147kj/d Dietary Protein: 0.8g/kg.d CRRT ( fluid > 5L/d),Management of ARF (四),Hyperkalemia K+6mmol/L 10%Calcium Gluconate 10-20ml 5% Sodium Bicarbonate 100-200ml 20% Gluco
23、se 3ml/kg.h+Insulin 0.5U/kg.h Dialysis,Management of ARF (五),Metabolic Acidosis HCO3-< 15mmol/L : 5% Sodium Bicarbonate 100-250ml Dialysis,Management of ARF,Other Electrolyte Disorder In
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
評(píng)論
0/150
提交評(píng)論